Valeant Pharmaceuticals International
$240,000,000 3.0% Convertible Subordinated Notes due 2010
This prospectus supplement relates to the resale by various selling securityholders of $240,000,000 aggregate principal amount of our 3.0% convertible subordinated notes due 2010, $240,000,000 aggregate principal amount of our 4.0% convertible subordinated notes due 2013 and shares of our common stock into which the notes are convertible. This prospectus supplement may only be delivered or used in connection with our prospectus dated August 6, 2004. Our common stock is quoted on the New York Stock Exchange under the symbol VRX.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
Prospectus Supplement dated August 16, 2004.
The information appearing in the following table supplements or supersedes in part the information in the table under the heading Selling Securityholders in our prospectus and was provided by or on behalf of the selling securityholders.
Principal Amount | ||||||||||||||||||
of Notes | Principal Amount | Number of Shares | Percentage | |||||||||||||||
Beneficially | of Notes Offered | of Common Stock | of Common | |||||||||||||||
Owned Prior to | by This | That May Be | Stock | |||||||||||||||
Name of Selling Securityholder(1) | This Offering | Prospectus | Sold(2) | Outstanding | ||||||||||||||
3.0% convertible subordinated notes due 2010 (CUSIP No. 91911XAA2) | ||||||||||||||||||
Drake Offshore Master Fund, Ltd
|
10,000,000 | 10,000,000 | 316,336 | * | ||||||||||||||
F.M. Kirby Foundation, Inc.
|
935,000 | 935,000 | 29,577 | * | ||||||||||||||
International Truck & Engine Corporation
Retiree Health Benefit Trust
|
275,000 | 275,000 | 8,699 | * | ||||||||||||||
International Truck & Engine Corporation
Retirement Plan for Salaried Employees Trust
|
405,000 | 405,000 | 12,811 | * | ||||||||||||||
LDG Limited
|
178,000 | 178,000 | 5,630 | * | ||||||||||||||
MSS Convertible Arbitrage 1 c/o TQA Investors, LLC
|
9,000 | 9,000 | 284 | * | ||||||||||||||
Partners Group Alternative Strategies PCC
Ltd.
|
400,000 | 400,000 | 12,653 | * | ||||||||||||||
Sphinx Fund c/o TQA Investors, LLC
|
201,000 | 201,000 | 6,358 | * | ||||||||||||||
Sturgeon Limited
|
450,000 | 450,000 | 14,235 | * | ||||||||||||||
TQA Master Fund Ltd.
|
1,617,000 | 1,617,000 | 51,151 | * | ||||||||||||||
TQA Master Plus Fund Ltd.
|
2,608,000 | 2,608,000 | 82,500 | * | ||||||||||||||
Travelers Indemnity Company Commercial
Lines
|
780,000 | 780,000 | 24,674 | * | ||||||||||||||
Travelers Indemnity Company Personal Lines
|
515,000 | 515,000 | 16,291 | * | ||||||||||||||
Xavex Convertible Arbitrage 7 Fund c/o TQA
Investors, LLC
|
568,000 | 568,000 | 17,967 | * | ||||||||||||||
Zurich Institutional Benchmarks Master Fund
|
||||||||||||||||||
Ltd. c/o TQA Investors, LLC
|
319,000 | 319,000 | 10,091 | * | ||||||||||||||
All other holders of 3.0% convertible
subordinated notes due 2010 or shares of common stock issued on
conversion of such notes and future transferees, pledgees,
donees, and successors thereof(3)
|
$ | 63,464,000 | $ | 63,464,000 | 2,007,594 | 2.33 | % | |||||||||||
4.0% convertible subordinated notes due 2013 (CUSIP No. 91911XAC8) | ||||||||||||||||||
CSS, LLC
|
2,000,000 | 2,000,000 | 63,267 | * | ||||||||||||||
Sturgeon Limited
|
390,000 | 390,000 | 12,337 | * | ||||||||||||||
All other holders of 4.0% convertible
subordinated notes due 2013 or shares of common stock issued on
conversion of such notes and future transferees, pledgees,
donees, and successors thereof(3)
|
$ | 106,723,000 | $ | 106,723,000 | 3,376,032 | 3.86 | ||||||||||||
* | Less than 1%. |
(1) | Information concerning the selling securityholders may change from time to time. Any such changed information will be set forth in amendments or supplements to our prospectus dated August 6, 2004, if and when required. |
(2) | Unless otherwise indicated, includes all shares of common stock issuable upon conversion of the notes and assumes a conversion rate of 31.6336 shares for each $1,000 principal amount of notes and a cash payment in lieu of any fractional share. However, this conversion rate will be subject to adjustment as described under Description of the Notes Conversion Rate Adjustments. As a result, the number of shares of common stock offered hereby may increase or decrease in the future. Also assumes that the notes are convertible immediately. As described above under Description of the Notes Conversion of Notes, the notes are convertible only in specified circumstances. |
(3) | Information concerning other selling securityholders will be set forth in amendments or supplements to our prospectus dated August 16, 2004, if required. |